首页> 美国卫生研究院文献>AAPS PharmSciTech >Influence of Process and Formulation Parameters on Dissolution and Stability Characteristics of Kollidon® VA 64 Hot-Melt Extrudates
【2h】

Influence of Process and Formulation Parameters on Dissolution and Stability Characteristics of Kollidon® VA 64 Hot-Melt Extrudates

机译:工艺和配方参数对Kollidon®VA 64热熔挤出物溶解度和稳定性的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of the present study was to investigate the effects of processing variables and formulation factors on the characteristics of hot-melt extrudates containing a copolymer (Kollidon® VA 64). Nifedipine was used as a model drug in all of the extrudates. Differential scanning calorimetry (DSC) was utilized on the physical mixtures and melts of varying drug–polymer concentrations to study their miscibility. The drug–polymer binary mixtures were studied for powder flow, drug release, and physical and chemical stabilities. The effects of moisture absorption on the content uniformity of the extrudates were also studied. Processing the materials at lower barrel temperatures (115–135°C) and higher screw speeds (50–100 rpm) exhibited higher post-processing drug content (~99–100%). DSC and X-ray diffraction studies confirmed that melt extrusion of drug–polymer mixtures led to the formation of solid dispersions. Interestingly, the extrusion process also enhanced the powder flow characteristics, which occurred irrespective of the drug load (up to 40% w/w). Moreover, the content uniformity of the extrudates, unlike the physical mixtures, was not sensitive to the amount of moisture absorbed. The extrusion conditions did not influence drug release from the extrudates; however, release was greatly affected by the drug loading. Additionally, the drug release from the physical mixture of nifedipine–Kollidon® VA 64 was significantly different when compared to the corresponding extrudates (f2 = 36.70). The extrudates exhibited both physical and chemical stabilities throughout the period of study. Overall, hot-melt extrusion technology in combination with Kollidon® VA 64 produced extrudates capable of higher drug loading, with enhanced flow characteristics, and excellent stability.
机译:本研究的目的是研究加工变量和配方因素对含共聚物(VA 64)的热熔挤出物特性的影响。硝苯地平被用作所有挤出物中的模型药物。差示扫描量热法(DSC)用于各种药物-聚合物浓度不同的物理混合物和熔体,以研究它们的混溶性。研究了药物-聚合物二元混合物的粉末流动性,药物释放以及物理和化学稳定性。还研究了水分吸收对挤出物含量均匀性的影响。在较低的料筒温度(115–135°C)和较高的螺杆转速(50–100 rpm)下加工材料显示出较高的后处理药物含量(〜99–100%)。 DSC和X射线衍射研究证实,药物-聚合物混合物的熔融挤出导致形成固体分散体。有趣的是,挤出工艺还增强了粉末流动特性,无论药物载量如何(最高40%w / w),粉末流动特性都会出现。此外,与物理混合物不同,挤出物的含量均匀性对吸收的水分量不敏感。挤出条件不影响药物从挤出物中的释放。然而,药物释放量极大地影响了释放。此外,与相应的挤出物相比,硝苯地平– VA 64物理混合物中的药物释放显着不同(f2 = 36.70)。在整个研究期间,挤出物表现出物理和化学稳定性。总体而言,将热熔挤出技术与Kollidon®VA 64结合使用可生产出具有更高载药量,增强的流动特性和出色稳定性的挤出物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号